As of 2024-07-27, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (17.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -215.7%.
The range of the Relative Valuation is (17.98) - (17.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 24.1x | 21.5x |
| Forward P/E multiples | 24.3x - 27.1x | 26.2x |
| Fair Price | (17.98) - (17.80) | (17.64) |
| Upside | -217.9% - -216.7% | -215.7% |
| Date | P/E |